These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 4351585)
1. Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera. Cooney MK; Kenny GE; Tam R; Fox JP Infect Immun; 1973 Mar; 7(3):335-40. PubMed ID: 4351585 [TBL] [Abstract][Full Text] [Related]
2. Is a rhinovirus vaccine possible? Fox JP Am J Epidemiol; 1976 Apr; 103(4):345-54. PubMed ID: 176887 [TBL] [Abstract][Full Text] [Related]
3. Antigenic groupings of 90 rhinovirus serotypes. Cooney MK; Fox JP; Kenny GE Infect Immun; 1982 Aug; 37(2):642-7. PubMed ID: 6288568 [TBL] [Abstract][Full Text] [Related]
4. Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes. Cooney MK; Wise JA; Kenny GE; Fox JP J Immunol; 1975 Feb; 114(2 Pt 1):635-9. PubMed ID: 47360 [TBL] [Abstract][Full Text] [Related]
5. Isolation of rhinovirus intertypes related to either rhinoviruses 12 and 78 or 36 and 58. Halfpap LM; Cooney MK Infect Immun; 1983 Apr; 40(1):213-8. PubMed ID: 6299958 [TBL] [Abstract][Full Text] [Related]
6. [Preparation of immune serums for the identification of rhinoviruses]. Dreizin RS; Ponomareva TI; Borovkova NM; Dukhovnaia EM; Vikhnovich EM Vopr Virusol; 1975; (4):498-501. PubMed ID: 175585 [TBL] [Abstract][Full Text] [Related]
7. Gel double immunodiffusion studies with sex human rhinoviruses. Smith CB Arch Virol; 1978; 57(3):231-41. PubMed ID: 209768 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal neutralizing cross-reaction between rhinovirus types 9 and 32. Cooney MK; Kenny GE J Immunol; 1970 Aug; 105(2):531-3. PubMed ID: 4317512 [No Abstract] [Full Text] [Related]
9. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405 [TBL] [Abstract][Full Text] [Related]
10. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Hierholzer JC; Stone YO; Broderson JR Arch Virol; 1991; 121(1-4):179-97. PubMed ID: 1759904 [TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children. Brüssow H; Offit PA; Sidoti J J Clin Microbiol; 1991 May; 29(5):869-73. PubMed ID: 1647406 [TBL] [Abstract][Full Text] [Related]
12. Antigenic relationships of common rhinovirus types from disabling upper respiratory illnesses. Mogabgab WJ; Holmes BJ; Pollock B Dev Biol Stand; 1975; 28():400-11. PubMed ID: 165120 [TBL] [Abstract][Full Text] [Related]
13. Haemagglutination-inhibiting and neutralizing antibodies to type 3 and 5 rhinoviruses in human sera and nasal washings. Strízová V; Hrusková J; Syrücek L; Brücková M; Berkovicová V J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):348-52. PubMed ID: 231069 [TBL] [Abstract][Full Text] [Related]
14. Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization. Bochkov YA; Devries M; Tetreault K; Gangnon R; Lee S; Bacharier LB; Busse WW; Camargo CA; Choi T; Cohen R; De R; DeMuri GP; Fitzpatrick AM; Gergen PJ; Grindle K; Gruchalla R; Hartert T; Hasegawa K; Khurana Hershey GK; Holt P; Homil K; Jartti T; Kattan M; Kercsmar C; Kim H; Laing IA; Le Souëf PN; Liu AH; Mauger DT; Pappas T; Patel SJ; Phipatanakul W; Pongracic J; Seroogy C; Sly PD; Tisler C; Wald ER; Wood R; Lemanske RF; Jackson DJ; Gern JE; J Med Virol; 2023 Aug; 95(8):e29058. PubMed ID: 37638498 [TBL] [Abstract][Full Text] [Related]
16. Preparation of rhinovirus antisera in the South American hystricomorph rodent, Octodon degus (38507). Phillips CA; Boraker DK Proc Soc Exp Biol Med; 1975 Jan; 148(1):208-10. PubMed ID: 165524 [TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846 [TBL] [Abstract][Full Text] [Related]
18. Hyper-antigenic variation occurs with human rhinovirus type 17. Patterson LJ; Hamparian VV J Virol; 1997 Feb; 71(2):1370-4. PubMed ID: 8995661 [TBL] [Abstract][Full Text] [Related]
19. Use of indirect immunofluorescence method for detection of rhinovirus-specific antibodies. Hrusková J; Strízová V; Syrŭcek L; Brûcková M J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):60-4. PubMed ID: 6262403 [TBL] [Abstract][Full Text] [Related]